Mary Kay Koenig News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Marinus Pharmaceuticals Announces Speakers for Hybrid Investor & Analyst Event on Tuesday, September

RADNOR, Pa. (BUSINESS WIRE) $MRNS #MarinusPharma Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the speakers for its upcoming Investor & Analyst Event on Tuesday, September 19 from 9:00 a.m..

New yorkUnited statesUniversity of texasNorth carolinaUniversity of north carolinaGeorge schoolJim denikeRajat dharLisa lejuwaanScott braunsteinFawada khanKristin rudisillMolly cameronHenri vaitkeviciusStevene pfanstielMary kay koenig

The fight against rare tumor disease moves to Houston

A clinical drug trial is underway in Houston for a rare tumor disease called tuberous sclerosis complex.

United statesUniversity of texasCorpus christiMary kay koenigNora navarCheryl navarUt health houstonUniversity of texas tuberous sclerosis centerRare diseaseTuberous sclerosis complexTuberous sclerosisTexas tuberous sclerosisAlamar parkHope northrupChannel 6Drug clinical

Moms mitochondria may refresh cells in sick kids | Science

Moms mitochondria may refresh cells in sick kids | Science
science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.

United statesUniversity of texasMary kay koenigElad jacobyMichael hannaUniversity of texas health science centerSheba medical centerTexas health science centerScience translationalUniversity college london queen square institute